7TM Pharma Successfully Conducts Clinical Phase I Trial of Its First in Class Peripheral CB1 Receptor Antagonist TM38837 Demonstrating Restriction from the Human CNS
11/11/2010 12:36:11 PM
More...
|
7TM Pharma Completes Positron Emission Tomography Preclinical Research Program To Successfully Demonstrate Peripheral Restriction Of Its CB1 Receptor Antagonist TM38837
7/12/2010 1:59:53 PM
More...
|
7TM Pharma: A Potential New Treatment For Cancer Supportive Care And Gastrointestinal Diseases
4/23/2010 1:54:45 PM
More...
|
7TM Pharma Successfully Conducts Clinical Phase I Trial With Its Second Generation CB1 Receptor Antagonist
2/4/2010 3:13:00 PM
More...
|
7TM Pharma Closes A Financing Round And Sells Certain Early Stage Discovery Assets And Technology To OSI Pharmaceuticals, Inc. (OSIP)
1/15/2009 11:50:26 AM
More...
|
7TM Pharma Has Initiated Phase I/IIa Clinical Trial with TM30339
9/2/2008 11:45:41 AM
More...
|
7TM Pharma Receives Milestone Payment from Asthma and Allergy Collaboration
4/16/2008 1:57:08 PM
More...
|
Dr. Reddy's Laboratories Ltd. (RDY)'s Enters Into Drug Discovery Collaboration With 7TM Pharma on Selected Drug Targets
3/10/2008 7:00:41 AM
More...
|
7TM Pharma Positive Results from Two Clinical Phase I Studies with the Drug Candidate TM30339 for the Treatment of Obesity
2/27/2008 8:46:57 AM
More...
|
7TM Pharma Announces Selection of a New Pre-clinical Development Candidate
2/6/2008 7:04:09 AM
More...
|
|